{"transactions":[{"id":2333870,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-15T23:34:41.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":25196,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25197,"derivative":{"exercise_price":14.4,"exercise_date":"2020-04-06","expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":25196},"source":{"system":"sec-edgar","filing":"0001061983-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000077/edgardoc.xml","form_type":"4"}},{"id":2333869,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-03-15T23:34:41.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":4803,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4804,"derivative":{"exercise_price":14.4,"exercise_date":"2020-04-06","expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":4803},"source":{"system":"sec-edgar","filing":"0001061983-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000077/edgardoc.xml","form_type":"4"}},{"id":2333868,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-03-15T23:34:41.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":30818,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13938,"derivative":{"exercise_price":7.03,"exercise_date":"2020-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":30818},"source":{"system":"sec-edgar","filing":"0001061983-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000077/edgardoc.xml","form_type":"4"}},{"id":2333867,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:34:41.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":25196,"price":33.9627,"value":855724.1892,"ownership":{"direct":true},"balance_after":103408,"source":{"system":"sec-edgar","filing":"0001061983-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000077/edgardoc.xml","form_type":"4"}},{"id":2333866,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:34:41.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":25196,"price":14.4,"value":362822.4,"ownership":{"direct":true},"balance_after":128604,"source":{"system":"sec-edgar","filing":"0001061983-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000077/edgardoc.xml","form_type":"4"}},{"id":2333865,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:34:41.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":4803,"price":14.4,"value":69163.2,"ownership":{"direct":true},"balance_after":103408,"source":{"system":"sec-edgar","filing":"0001061983-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000077/edgardoc.xml","form_type":"4"}},{"id":2333864,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T23:34:41.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":30818,"price":7.03,"value":216650.54,"ownership":{"direct":true},"balance_after":98605,"source":{"system":"sec-edgar","filing":"0001061983-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000077/edgardoc.xml","form_type":"4"}},{"id":2345232,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-08T23:47:16.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":4631,"price":36.83,"value":170559.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/07/2022 and does not represent a sale by the reporting person."}],"balance_after":67787,"source":{"system":"sec-edgar","filing":"0001061983-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000070/edgardoc.xml","form_type":"4"}},{"id":2356272,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-03T21:41:33.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":41138,"price":37.63,"value":1548022.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":41138,"derivative":{"exercise_price":37.63,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":41138},"source":{"system":"sec-edgar","filing":"0001061983-22-000056","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000056/edgardoc.xml","form_type":"4"}},{"id":2356271,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-03-03T21:41:33.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":3862,"price":37.63,"value":145327.06,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":3862,"derivative":{"exercise_price":37.63,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":3862},"source":{"system":"sec-edgar","filing":"0001061983-22-000056","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000056/edgardoc.xml","form_type":"4"}},{"id":2356270,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-03T21:41:33.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant."}],"balance_after":72418,"source":{"system":"sec-edgar","filing":"0001061983-22-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000056/edgardoc.xml","form_type":"4"}},{"id":2356269,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-03-03T21:41:33.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":3457,"price":37.63,"value":130086.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/02/2022 and does not represent a sale by the reporting person."}],"balance_after":52418,"source":{"system":"sec-edgar","filing":"0001061983-22-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000056/edgardoc.xml","form_type":"4"}},{"id":2389368,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-02-18T00:48:21.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of restricted stock units (RSUs) issued upon conversion of certain PSUs granted to the Reporting Person on May 11, 2021. The satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into RSUs of the Issuer. These RSUs will vest in whole on February 16, 2023."}],"balance_after":55875,"source":{"system":"sec-edgar","filing":"0001061983-22-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000028/edgardoc.xml","form_type":"4"}},{"id":2389367,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2022-02-18T00:48:21.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On or about May 11, 2021, the Reporting Person was granted performance-based stock units (PSUs) of the Issuer, which upon satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into fully-vested shares of common stock of the Issuer."}],"balance_after":52750,"source":{"system":"sec-edgar","filing":"0001061983-22-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000028/edgardoc.xml","form_type":"4"}},{"id":2538392,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-10-20T22:57:47.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":19979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 30, 2021."}],"balance_after":15265,"derivative":{"exercise_price":7.03,"exercise_date":"2020-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":19979},"source":{"system":"sec-edgar","filing":"0001061983-21-000241","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000241/edgardoc.xml","form_type":"4"}},{"id":2538391,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2021-10-20T22:57:47.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":19979,"price":35.736,"value":713969.544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 30, 2021."}],"balance_after":50850,"source":{"system":"sec-edgar","filing":"0001061983-21-000241","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000241/edgardoc.xml","form_type":"4"}},{"id":2538390,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2021-10-20T22:57:47.000Z","date":"2021-10-19","kind":"exercise","acquired":true,"shares":19979,"price":7.03,"value":140452.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 30, 2021."}],"balance_after":70829,"source":{"system":"sec-edgar","filing":"0001061983-21-000241","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000241/edgardoc.xml","form_type":"4"}},{"id":2800918,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2021-03-09T23:56:15.000Z","date":"2021-03-08","kind":"tax_withholding","acquired":false,"shares":4150,"price":19.19,"value":79638.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/06/2021 and does not represent a sale by the reporting person."}],"balance_after":50850,"source":{"system":"sec-edgar","filing":"0001061983-21-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000078/edgardoc.xml","form_type":"4"}},{"id":2809501,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-04T21:57:47.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":34871,"price":19.42,"value":677194.82,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":34871,"derivative":{"exercise_price":19.42,"exercise_date":"2021-04-02","expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":34871},"source":{"system":"sec-edgar","filing":"0001061983-21-000061","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000061/edgardoc.xml","form_type":"4"}},{"id":2809500,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-03-04T21:57:47.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":10129,"price":19.42,"value":196705.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":10129,"derivative":{"exercise_price":19.42,"exercise_date":"2021-04-02","expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":10129},"source":{"system":"sec-edgar","filing":"0001061983-21-000061","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000061/edgardoc.xml","form_type":"4"}},{"id":2809499,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2021-03-04T21:57:47.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock  units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0001061983-21-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000061/edgardoc.xml","form_type":"4"}},{"id":3050191,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-21T21:34:59.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 23, 2020."}],"balance_after":35244,"derivative":{"exercise_price":7.03,"exercise_date":"2020-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-20-000143","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000143/edgardoc.xml","form_type":"4"}},{"id":3050190,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2020-08-21T21:34:59.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":10000,"price":25,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 23, 2020."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001061983-20-000143","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000143/edgardoc.xml","form_type":"4"}},{"id":3050189,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2020-08-21T21:34:59.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":10000,"price":7.03,"value":70300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 23, 2020."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001061983-20-000143","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000143/edgardoc.xml","form_type":"4"}},{"id":3073570,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-30T23:57:03.000Z","date":"2020-07-29","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 23, 2020."}],"balance_after":45244,"derivative":{"exercise_price":7.03,"exercise_date":"2020-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-20-000135","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000135/edgardoc.xml","form_type":"4"}},{"id":3073569,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2020-07-30T23:57:03.000Z","date":"2020-07-29","kind":"sale","acquired":false,"shares":10000,"price":23.0728,"value":230728.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 23, 2020."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001061983-20-000135","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000135/edgardoc.xml","form_type":"4"}},{"id":3073568,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2020-07-30T23:57:03.000Z","date":"2020-07-29","kind":"exercise","acquired":true,"shares":10000,"price":7.03,"value":70300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 23, 2020."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001061983-20-000135","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000135/edgardoc.xml","form_type":"4"}},{"id":3221119,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-09T20:33:39.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":50393,"price":14.4,"value":725659.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":50393,"derivative":{"exercise_price":14.4,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":50393},"source":{"system":"sec-edgar","filing":"0001061983-20-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000064/edgardoc.xml","form_type":"4"}},{"id":3221118,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-03-09T20:33:39.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":9607,"price":14.4,"value":138340.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":9607,"derivative":{"exercise_price":14.4,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":9607},"source":{"system":"sec-edgar","filing":"0001061983-20-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000064/edgardoc.xml","form_type":"4"}},{"id":3221117,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Common Stock","published_at":"2020-03-09T20:33:39.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001061983-20-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000064/edgardoc.xml","form_type":"4"}},{"id":3678005,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-02-04T21:38:12.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":55244,"price":7.03,"value":388365.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"When the ISO and NQ dated 01/31/2019 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 25,000 shares on 01/31/2020 and the balance of 75,000 divided into equal monthly installments thereafter such that the option shall be 100% vested on 01/31/2023."}],"balance_after":55244,"derivative":{"exercise_price":7.03,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":55244},"source":{"system":"sec-edgar","filing":"0001061983-19-000015","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198319000015/edgardoc.xml","form_type":"4"}},{"id":3678004,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Legal & General Counsel"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-02-04T21:38:12.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":44756,"price":7.03,"value":314634.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"When the ISO and NQ dated 01/31/2019 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 25,000 shares on 01/31/2020 and the balance of 75,000 divided into equal monthly installments thereafter such that the option shall be 100% vested on 01/31/2023."}],"balance_after":44756,"derivative":{"exercise_price":7.03,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":44756},"source":{"system":"sec-edgar","filing":"0001061983-19-000015","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198319000015/edgardoc.xml","form_type":"4"}},{"id":3943078,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":21.24,"expiration_date":"2021-07-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943077,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":21667,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":20.9,"expiration_date":"2022-05-23","underlying":"Common Stock","underlying_shares":21667},"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943076,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":52000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":17.99,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943075,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":25.24,"expiration_date":"2024-05-14","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943074,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":47500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":40.7,"expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943073,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":52801,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":33.27,"expiration_date":"2026-02-26","underlying":"Common Stock","underlying_shares":52801},"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943072,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":56232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":9.35,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":56232},"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943071,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Restricted Common Stock","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":18135,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares of restricted stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock. Represents net amount of shares exchanged after required tax withholding with respect to such vesting."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of restricted stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock. Represents net amount of shares exchanged after required tax withholding with respect to such vesting."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":3943070,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-05-08T16:16:10.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":50116,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000081","document":"wf-form4_152581055657326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000081/wf-form4_152581055657326.xml","form_type":"4"}},{"id":4017022,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-03-05T12:47:23.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":3273,"price":19.5,"value":63823.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Schlossberg's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":89246,"source":{"system":"sec-edgar","filing":"0001003642-18-000047","document":"wf-form4_152027203026483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000047/wf-form4_152027203026483.xml","form_type":"4"}},{"id":4031431,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-02-27T12:18:18.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":5937,"price":20.95,"value":124380.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of two restricted stock awards to satisfy Mr. Schlossberg's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":92519,"source":{"system":"sec-edgar","filing":"0001003642-18-000022","document":"wf-form4_151975188040385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000022/wf-form4_151975188040385.xml","form_type":"4"}},{"id":4319110,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2017-05-16T14:56:59.000Z","date":"2017-05-15","kind":"tax_withholding","acquired":false,"shares":3488,"price":16.8,"value":58598.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Schlossberg's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":98456,"source":{"system":"sec-edgar","filing":"0001003642-17-000046","document":"wf-form4_149496100533907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000046/wf-form4_149496100533907.xml","form_type":"4"}},{"id":4319109,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2017-05-16T14:56:59.000Z","date":"2017-05-14","kind":"tax_withholding","acquired":false,"shares":3235,"price":17.65,"value":57097.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Schlossberg's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":101944,"source":{"system":"sec-edgar","filing":"0001003642-17-000046","document":"wf-form4_149496100533907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000046/wf-form4_149496100533907.xml","form_type":"4"}},{"id":4401187,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-06T15:08:59.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":56232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments beginning on March 2, 2018, which is the first anniversary of the grant date."}],"balance_after":56232,"derivative":{"exercise_price":9.35,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":56232},"source":{"system":"sec-edgar","filing":"0001003642-17-000020","document":"wf-form4_148883092487946.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000020/wf-form4_148883092487946.xml","form_type":"4"}},{"id":4401186,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2017-03-06T15:08:59.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":23272,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105179,"source":{"system":"sec-edgar","filing":"0001003642-17-000020","document":"wf-form4_148883092487946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000020/wf-form4_148883092487946.xml","form_type":"4"}},{"id":4422566,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":129126,"kind":"person","name":"SCHLOSSBERG MARK A","position":1,"cik":"0001520533","reported_name":"SCHLOSSBERG MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2017-02-27T20:22:17.000Z","date":"2017-02-26","kind":"tax_withholding","acquired":false,"shares":6014,"price":14.05,"value":84496.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of two restricted stock awards to satisfy Mr. Schlossberg's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":81907,"source":{"system":"sec-edgar","filing":"0001003642-17-000011","document":"wf-form4_148824492355818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000011/wf-form4_148824492355818.xml","form_type":"4"}}]}